-
1by Kay Warner, Wolf See, David Haerry, Ingrid Klingmann, Amy Hunter, Matthew MaySubjects: “...pharmaceutical industry-led medicines R&D...”
Published 2018-10-01
Get full text
Article -
2by Ingrid Klingmann, Andrea Heckenberg, Kay Warner, David Haerry, Amy Hunter, Matthew May, Wolf See“... areas of indications—today is a widely accepted strategy in pharmaceutical industry to ensure relevance...”
Published 2018-09-01
Get full text
Article -
3by David Haerry, Cordula Landgraf, Kay Warner, Amy Hunter, Ingrid Klingmann, Matthew May, Wolf See“...) was to close this gap through the development of guidance documents for pharmaceutical industry-led medicines R...”
Published 2018-08-01
Get full text
Article -
4by Amy Hunter, Amy Hunter, Karen Facey, Karen Facey, Victoria Thomas, Victoria Thomas, David Haerry, David Haerry, Kay Warner, Kay Warner, Ingrid Klingmann, Ingrid Klingmann, Matthew May, Matthew May, Wolf See, Wolf See“... in pharmaceutical industry-led research and development, ethics committees, and regulatory authorities. The guidance...”
Published 2018-09-01
Get full text
Article